Joint Session of American Board of Foot Surgeons and American Association of Medical Foot Specialists to welcome pharmaceutical compounding expert

Bronx, NY (Feb.10, 2014) – Dr. Emil J. Haldey, president of New York City-based HALDEY Pharmaceutical Compounding, will speak this week before an audience of doctors at the joint session of American Board of Foot Surgeons and American Association of Medical Foot Specialists.

The event will take place on Wednesday, Feb. 12, from 6 to 9 p.m., in Maestro Caterers, 1703 Bronxdale Ave., Bronx, N.Y.

Dr. Haldey, a doctor of pharmacy, will discuss the history, rationale and benefits of prescription-drug compounding for modern medical and podiatry practices. His talk will cover common pathologies and customized-therapy considerations in various fields of medicine, such as pain management, dermatology, podiatry, etc. Special attention will be given to common pathologies seen in the podiatric practice, such as neuropathic and other pain conditions, plantar fasciitis, warts, and more.

About HALDEY Pharmaceutical Compounding

New York City-based HALDEY Pharmaceutical Compounding, as its name implies, specializes in pharmaceutical compounding. The enterprise focuses solely on tailoring prescriptions to meet the specific needs of each individual patient, including those dealing with unique medical circumstances.

HALDEY Pharmaceutical Compounding’s innovative scientific solutions embrace a host of medical and quality-of-life issues, such as pain management; anti-aging and integrative medicine; holistic health; hospice care; dermatology, and health and wellness, to name just a few.

For additional information, HALDEY Pharmaceutical Compounding may be reached at 855-H-COMPOUND (855-426-6768), or via the company’s Website: www.hcompound.com.

American Board of Foot Surgeons and American Association of Medical Foot Specialists may be reached at (646) 229-4010.